Article Text

Download PDFPDF
Environment and invironment in IBDs: partners in crime
  1. Peter Laszlo Lakatos1,
  2. Johan Burisch2
  1. 11st Department of Medicine, Semmelweis University, Budapest, Hungary
  2. 2Gastrounit, Medical Section, Hvidovre University Hospital, Hvidovre, Denmark
  1. Correspondence to Dr Peter Laszlo Lakatos, 1st Department of Medicine, Semmelweis University, Koranyi st. 2/A, Budapest H-1083, Hungary; lakatos.peter_laszlo{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

IBD are chronic inflammatory disorders of the GI tract of unknown aetiology. Crohn's disease (CD) and UC may present with a variable clinical phenotype, and they run a highly variable disease course with a considerable proportion of patients with CD eventually developing penetrating or stricturing complications.1 The key mechanism underlying the pathogenesis of these diseases is assumed to be a dysregulated immune response to commensal flora in a genetically susceptible host.2 Thus, host genetics, the intestinal microbiota (commensal flora and dysbiosis) and external environmental factors are all thought to play an important role in the pathogenesis and in determining subsequent disease behaviour and outcomes. Genetic and recently microbiota research became a success story leading to a revolution in our understanding of the pathogenesis of IBDs and gave insight into the biology leading to new targeted treatment options. It all began with the identification of NOD2/CARD15 and unravelling the importance of innate immunity and defective bacterial sensing in 2001. Since then we have witnessed a rapid acceleration of gene discovery catalysed by the advent of genome-wide association studies, thanks to large collaborations of national and international groups.3 As of today, more than 160 IBD loci have been identified and these risk loci highlight several key pathways including innate immunity, adaptive immune responses, maintenance of intestinal barrier function, pathogen sensing, endoplasmic reticulum stress and response to oxidative stress.4 Of note, some important differences were noted between Europe and Asia (e.g. NOD2 or TNFSF15). In addition, most …

View Full Text


  • Contributors Both authors have contributed equally to the designing and writing of this commentary.

  • Competing interests None.

  • Provenance and peer review Commissioned; internally peer reviewed.

Linked Articles

  • Inflammatory bowel disease
    Siew C Ng Whitney Tang Rupert W Leong Minhu Chen Yanna Ko Corrie Studd Ola Niewiadomski Sally Bell Michael A Kamm H J de Silva Anuradhani Kasturiratne Yasith Udara Senanayake Choon Jin Ooi Khoon-Lin Ling David Ong Khean Lee Goh Ida Hilmi Qin Ouyang Yu-Fang Wang PinJin Hu Zhenhua Zhu Zhirong Zeng Kaichun Wu Xin Wang Bing Xia Jin Li Pises Pisespongsa Sathaporn Manatsathit Satimai Aniwan Marcellus Simadibrata Murdani Abdullah Steve W C Tsang Tai Chiu Wong Aric J Hui Chung Mo Chow Hon Ho Yu Mo Fong Li Ka Kei Ng Jessica Ching Justin C Y Wu Francis K L Chan Joseph J Y Sung